Ligand Pharmaceuticals Inc. (OQ:LGND)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for LGND within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 12/19 Jun 11/19 Aryeh Jason Direct Ownership Common Stock P - Open market or private purchase 250 $107.01
Jun 12/19 Jun 11/19 Foehr Matthew W Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,004  
Jun 12/19 Jun 11/19 Foehr Matthew W Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,004 $21.92
Jun 10/19 Jun 6/19 Sabba Stephen L Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,071  
Jun 10/19 Jun 6/19 Sabba Stephen L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 835  
Jun 7/19 Jun 6/19 Aryeh Jason Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,071  
Jun 7/19 Jun 6/19 Aryeh Jason Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 835  
Jun 7/19 Jun 6/19 Davis Todd C Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,071  
Jun 7/19 Jun 6/19 Davis Todd C Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 835  
Jun 7/19 Jun 6/19 Gray Nancy Ryan Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,071  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for LGND within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 12/19 Jun 11/19 Aryeh Jason Direct Ownership Common Stock P - Open market or private purchase 250 $107.01
Jun 12/19 Jun 11/19 Foehr Matthew W Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,004  
Jun 12/19 Jun 11/19 Foehr Matthew W Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,004 $21.92
Jun 10/19 Jun 6/19 Sabba Stephen L Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,071  
Jun 10/19 Jun 6/19 Sabba Stephen L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 835  
Jun 7/19 Jun 6/19 Aryeh Jason Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,071  
Jun 7/19 Jun 6/19 Aryeh Jason Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 835  
Jun 7/19 Jun 6/19 Davis Todd C Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,071  
Jun 7/19 Jun 6/19 Davis Todd C Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 835  
Jun 7/19 Jun 6/19 Gray Nancy Ryan Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,071  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $LGND

StockTwits